Preclinical Evaluation of Cardiovascular, Hepato-protective, Anti-cancer, Analgesic, Anti-inflammatory and Anti-oxidant Agents Using Animal Models: An Over View
American Journal of Pharmacology and Pharmacotherapeutics · 2018
DOI: 10.21767/2393-8862.100016 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Pharmacology and Pharmacotherapeutics, 2018. Verfasst von Dawood Shaik und 1 weiteren Autor:innen.
Abstract (Originalsprache)
It is very important for an innovator to select appropriate animal models for the preclinical evaluation. The preclinical evaluation cannot be accomplished with the proper animal care and maintaining a good laboratory practices. This study illustrate the various factors involve in the animal study and role of various regulatory bodies in controlling the animal studies.
Zitieren
APA
Shaik, D., & Yusufuddin, M. (2018). Preclinical Evaluation of Cardiovascular, Hepato-protective, Anti-cancer, Analgesic, Anti-inflammatory and Anti-oxidant Agents Using Animal Models: An Over View. American Journal of Pharmacology and Pharmacotherapeutics. https://doi.org/10.21767/2393-8862.100016
Vancouver
Shaik D, Yusufuddin M. Preclinical Evaluation of Cardiovascular, Hepato-protective, Anti-cancer, Analgesic, Anti-inflammatory and Anti-oxidant Agents Using Animal Models: An Over View. American Journal of Pharmacology and Pharmacotherapeutics. 2018. doi:10.21767/2393-8862.100016
BibTeX
@article{Shaik2018,
author = {Shaik, Dawood and Yusufuddin, Mohammad},
title = {Preclinical Evaluation of Cardiovascular, Hepato-protective, Anti-cancer, Analgesic, Anti-inflammatory and Anti-oxidant Agents Using Animal Models: An Over View},
journal = {American Journal of Pharmacology and Pharmacotherapeutics},
year = {2018},
doi = {10.21767/2393-8862.100016}
}
EUVIMED